Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Acerta Pharma BV
Scientific Title
A Randomized, Multicenter, Open-Label, Non-Inferiority, Phase 3 Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia